ResearcherUniversity of California, San FranciscoNo recent work listed
Gérard I. Evan
Matched on ORCID iD 0000-0003-0412-1216; OpenAlex author ID A5042437588. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 26
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Co-author DOI 10.1038/s41467-023-40798-6↗
- MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype. Last author DOI 10.1158/2159-8290.cd-19-0435↗
- Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-1409↗
- Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-14-2852↗
Closest collaborators
The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nicole M. Sodir · 3 shared papers, 2015–2023 · strength 0.26
- Paper A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. DOI 10.1038/s41467-023-40798-6↗
- Paper MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype. DOI 10.1158/2159-8290.cd-19-0435↗
- Paper Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. DOI 10.1158/0008-5472.can-14-2852↗
- Laura Soucek · 2 shared papers, 2015–2020 · strength 0.15
- David J. Propper · 1 shared paper, 2023 · strength 0.12
- Corina E. Antal · 1 shared paper, 2023 · strength 0.12
- Jan C. Lumibao · 1 shared paper, 2023 · strength 0.12
- Haiyong Han · 1 shared paper, 2023 · strength 0.12
- Andrew M. Lowy · 1 shared paper, 2023 · strength 0.12
- Dannielle D. Engle · 1 shared paper, 2023 · strength 0.12
- Erkut Hasan Borazanci · 1 shared paper, 2023 · strength 0.12
- Ronald M. Evans · 1 shared paper, 2023 · strength 0.12
- Hervé Tiriac · 1 shared paper, 2023 · strength 0.12
- Daniel D. Von Hoff · 1 shared paper, 2023 · strength 0.12
- Michael T. Barrett · 1 shared paper, 2023 · strength 0.12
- Kay F. Macleod · 1 shared paper, 2019 · strength 0.08
- Gina M. DeNicola · 1 shared paper, 2019 · strength 0.08
- Brinda Alagesan · 1 shared paper, 2019 · strength 0.08
- Pedro Antonio Pérez-Mancera · 1 shared paper, 2019 · strength 0.08
- Karen H. Vousden · 1 shared paper, 2019 · strength 0.08
- Timothy J. Humpton · 1 shared paper, 2019 · strength 0.08
- Carl-Stephan Leonhardt · 1 shared paper, 2019 · strength 0.08
- Youngkyu Park · 1 shared paper, 2019 · strength 0.08
- David Arthur Tuveson · 1 shared paper, 2019 · strength 0.08
- Kim Pedersen · 1 shared paper, 2015 · strength 0.05
- Toni Jauset · 1 shared paper, 2015 · strength 0.05
- Daniel Massó-Vallés · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.